BlinkLab’s autism product gets global check
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the positive outcome from the US Food and Drug Administration from BlinkLab.
News
Fed triggers Wall Street (and ASX) sell-off
The ASX plunged nearly 2pc earlier, as a brutal Wall Street sell-off followed the Fed’s cautious outlook, signalling just two rate cuts for 2025.
Guy on Rocks: MNB
Guy Le Page looks into Minbos Resources and a phosphate opportunity to build a breadbasket in a nation which imports all of its fertiliser.
Stem-cell treatment gets breakthrough FDA approval
After years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host disease.
Volkswagen buys stake in PMT
Stockhead TV’s Sarah Hughan delves into a Volkswagen deal with Patriot Battery Metals and its North American lithium.
Brinsden’s Patriot inks major lithium deal
Volkswagen battery subsidiary PowerCo will pay C$69 million for a 9.9% stake in Canadian lithium hopeful Patriot Battery Metals.
Webull: 4 factors to boost ASX in 2025
Webull’s Talevski predicts rate cuts and US market momentum will boost the ASX in 2025, with the mining sector leading growth.
Why Copper M&A is just starting
Every major has copper at the top of its wishlist. And if you thought 2024’s M&A rush was big, just wait for what 2025 has in store.
Mali gold miners see support
Is the worst over for Mali gold miners? Bets today on ASX gold names suggest some investors may think so.
ASX slips as Fed looms
The ASX closed just into the red on Wednesday, ahead of another important Fed decision.
Rhythm hits 2024 key milestones
Predictive cancer diagnostics company Rhythm Biosciences reports it has attained all key milestones for 2024.
ASX up as MinRes seals $780m deal
ASX steadies ahead of the Fed decision. Mining leads but Percheron’s value plummets after poor trial results.
Break it Down: Pennys Find PFS
Sarah Hughan tells all on Horizon Minerals’ PFS and ore reserve for its Pennys Find project in WA’s Eastern Goldfields.
Percheron shares tumble on clinical trial failure
Percheron Therapuetic’s key trial for Duchenne muscular dystrophy has flopped, sending the shares into freefall.
The ASX resources sector looks strong in 2025
Investment manager Emanuel Datt believes Australia’s resources sector is emerging as a strong opportunity in 2025 and narrows in on three stocks.
Painchek eyes lucrative US market
Having tackled the local and UK aged-care markets, Painchek has its eyes on the much bigger US nursing home sector.
Speeding ticket can’t slow Cyclone
Cyclone Metals rose for a second straight trading day on no news, while BPM wrapped up drilling near the Mt Gibson gold mine.
ASX leaps; Novonix, Bitcoin soar
The ASX rose on Tuesday, with banks leading, while energy lagged. As for Bitcoin… its moon mission continues.
Datt forecasts US$3000/oz gold
Datt Capital founder and chief investment officer Emanuel Datt forecasts gold prices will continue to rise and may soon hit $US3000/oz.
ASX up; Bitcoin hits record on US reserve plans
The ASX opened higher on Tuesday but energy stocks weighed on the index. Meanwhile Bitcoin hit another record high amid US reserve plans.
Clinical trials results flow fast in pre-yuletide rush
The year is ending with an ongoing strong flow of clinical results – and is unlikely to abate in 2026.
Novonix’ potential US$755m loan
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the proposed synthetic graphite plant in the US from Novonix.
Intra Energy outlines strong gold anomaly at Maggie Hays Hill ahead of drilling
Intra Energy outlines strong gold anomaly at Maggie Hays Hill ahead of drilling
ASX rallies 1.75pc on easing inflation read
ASX surges 1.75pc after CPI “good enough to rule out an interest rate hike”.
Stockhead: ASX Small Caps Weekly Wrap
Despite a horror Friday, the market managed a win this week.
Top 10 at 11: Fresh from the ASX today
Stockhead’s Top 10 at 11: a short, sharp update to help frame the trading day.
ASX up; CBA, Mac Bank hit records; Aruma doubles
UBS analysts recommend buying ASX bank stocks due to better short-term prospects despite high valuations.
All you need to know before the ASX opens
Here’s everything you need to know, and some things you don’t, before the ASX opens today.
Benchmark and goldies in good form
Local benchmark ticks up after solid showing on Wall Street late Friday.
MinRes falters as Ordell soars on gold find
ASX closes higher despite a big dip in Mineral Resources, while the US dollar weakens amid uncertain election polling.
Why gold could outperform under Trump
Trump’s imminent return to the White House has brought a dive in gold prices. But experts think that could be short-lived.
Crucible: Dr Boreham’s A-To-Z of 2024 biotech
From AI to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster.
Can Adore Beauty’s new CEO turn it around?
Adore Beauty faces growth challenges but new CEO Sacha Laing is aiminf for a 30pc revenue boost and tripling of margins in three years.
Control Bionics eyes ‘near term’ profitability
Assistive communications group Control Bionics says it has overcome recent challenges including slow NDIS billing.
Iltani up on high-grade silver
Iltani surges on silver hit, Emmerson in gold takeover frame says Bridge Street and Patriot revives Zambian copper deal.
Santa rally stalls as China data hits
The ASX dropped on Monday as miners and tech slid and China’s weak data impacted commodities. Meanwhile, Bitcoin hit ANOTHER record high.
Iron ore drags miners; Digico drops again
Iron ore drags ASX miners, Digico and Ventia slump, Chalmers announces RBA shake-up.
Anteris debuts on the Nasdaq exchange
The heart valve innovator has started trading on the Nasdaq, as part of a US$88 million initial public offer.
Silver deposit already “looks like a mine”
Market observers are buzzing about the potential of Maronan Metals’ Queensland silver deposit of the same name.
Commsec’s ASX “Strong Buys”
Top “strong buy” stocks include Life360, West African Resources, and leaders in mining, biotech, and energy.
Crisis? What crisis? Troubled shares will (usually) recover
Investors can profit from investing in the midst of a corporate disaster – but they need nerves of steel.
ASX set for weekly loss as miners, real estate slump
The ASX drops as Wall Street weakness weighs on sentiment, with Insignia outperforming and Rio Tinto slumping.
Auric Mining banks another $5M
arah Hughan tells all on Auric Mining’s $5.2m returns from the latest round of gold sales at its Jeffreys Find mine near Norseman in WA’s Goldfields.
Why 2025 could be the year for ASX small caps
ASX small caps could rebound in 2025, Shaw and Partners analysts say, with lower interest rates boosting growth along with diversification and returns.
James Bay on fast track in Nevada
While miners say red tape is making Australia increasingly uncompetitive, the same can’t be said of Nevada, where junior goldie James Bay is thriving.
ASX slides; DigiCo REIT drops on IPO debut
The ASX hits near 4-week low, led by losses in miners, as DigiCo Infrastructure REIT underwhelms in IPO debut today
What is Project 2025 and its ESG impact?
Project 2025 pushes US reforms, raises climate risks, and could impact Australia’s trade and security.
Analysing Sonic’s $700m German health deal
Morgans analyst Scott Power places his watchful eye on the ASX healthcare sector’s big story this week: Sonic Healthcare’s ~$700 million deal to buy a major German laboratory group.
Raiden drills spinning, results expected soon
While drilling is underway at Target area 7, Raiden also expects to imminently receive results from earlier drilling at Andover South.
Gold catalysts laid bare for 2025
The World Gold Council sees “rangebound” gold prices in 2025 with potential upside after strongest growth in over a decade.
Rio goes all in on lithium
Rio Tinto has reinforced its conviction lithium prices will rebound, pledging US$2.5bn ($3.9bn) to build the 60,000tpa Rincon project in Argentina.
IML fundie believes Hipages is undervalued
As the tradies market embraces digitalisation, Hipages is positioning itself to capitalise and capture the $141 billion local industry.
2025 IPO hopeful tackling global “infant killer”
Slated to list on the ASX next year, Nexsen Biotech has developed a simple device to diagnose the infant killer group B streptococcus.
Net zero goals still need hydrogen
Heavy transport and displacing fossil fuel-derived hydrogen are some of the key areas where clean hydrogen can shine.
Argentine lithium junior drawing major eyes
Pursuit Minerals says its increased resource in Argentina opens the door to significant offtake discussions despite sluggish lithium prices.
Pilbara up on insider buys, Bitcoin surges again
The ASX ended lower on Thursday after a stronger-than-expected jobs report, while Downer EDI and Venti plunged after price-fixing allegations by ACCC.
Aldoro teases niobium discovery
More niobium rich surface samples have punters hoping for something big from Aldoro’s diamond drilling at the Kameelburg project.
ASX rebound scuttled by jobless rate
Despite an initial Wall Street-induced rebound, the ASX has retreated on Thursday after the unemployment rate unexpectedly fell to 3.9pc in November, defying expectations.
What does ‘sensible’ crypto regulation look like?
Eric Trump’s reiteration this week that his father’s administration will bring “sensible regulation” to crypto landed like a lightning bolt in an industry waiting for clarity.
Meteoric Resources’ high-grade rare earths results
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the Caldeira rare earth ionic clay project in Brazil from Meteoric Resources.
LTR Pharma celebrates online access for ED spray
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the online healthcare platform to access erectile dysfunction treatment from LTR Pharma.
M&A on the cards as cash slows
Mergers and acquisitions are on the agenda for explorers in 2025, with new figures showing how cash is drying up for small miners.
The first battery metal to rebound
Chinese export controls have thrown graphite back into the spotlight, with experts liking its long term outlook.
How many Carlow Castles can Artemis find?
Artemis Resources is taking inspiration from De Grey’s Hemi, hunting for repeats of its 704,000oz gold equivalent Carlow Castle deposit in the Pilbara.
ASX uranium plays claim unwanted title
Drumroll… uranium play Paladin Energy is the most shorted stock on the ASX, while Boss Energy is second.
Tech stocks dip as traders await US CPI data
ASX tech stocks continued to slide on hump day, while gold rebounded ahead of US CPI data and South32 dropped on Mozambique unrest.
This fundie caught the gold boom early
A pivot to gold miners ahead of this year’s bullion boom has led to positive returns for Stephen Gorenstein at the Ari Fund.
ASX juniors are drilling hard into Xmas
In spite of market challenges, these small-cap resources companies have remained steadfast in their exploration and drilling goals.
Pharma/chemist union turns heads
Morgans healthcare analyst Scott Power had his eyes on Sigma Healthcare this week, which soared after the ACCC approves its merger with Chemist Warehouse.
Silex Systems uranium tech in the draw for US billions
Sarah Hughan unfurls the Silex Systems selection as a uranium enrichment awardee by the US Department of Energy.
Sunshine’s substantial expansion
Sarah Hughan reveals all on a Sunshine Metals upgrade which placed Ravenswood Consolidated as one of Queensland’s larger undeveloped gold and base metals projects.
ASX slips, S32 tumbles amid Mozambique unrest
South32 has dropped on Wednesday on Mozambique unrest, while Chemist Warehouse plans an ASX listing after merging with Sigma.
The race is on for the next blood-cancer drugs
Syntara hopes to emulate the success of Ojjaara, a $2.6 billion home-grown myelofibrosis therapy approved in the US.
Is nuclear energy more eco-friendly than renewables?
Research firm Goehring & Rozencwajg believes nuclear energy trumps the green credentials of renewables thanks to small modular reactors.
Navarre heads back to its roots
$10 million capped Victorian gold explorer Navarre Minerals is getting ready to drill as the revived junior heads back to its roots.
FireFly lights up on copper hit
Steve Parsons’ FireFly Metals was the toast of the town on Tuesday with high-grade copper hits at its Green Bay project in Canada.
ASX pares losses as RBA eases rate-hike tone
The RBA held rates at 4.35pc, with the ASX paring losses as mining stocks rose and tech shares fell after China’s policy shift.
Desert Metals strikes gold at King Kong prospect
Sarah Hughan divulges on Desert Metals’ drilling which confirmed potential to host a significant gold system in the underexplored greenstone of Cote d’Ivoire.
ASX dips as tech slump slows mining rally
The ASX200 has slipped a tad so far on Tuesday, despite a mining rally driven by China’s stimulus signals.
ReNerve’s exclusive Middle East agreement
Sarah Hughan reveals all on ReNerve’s exclusive distribution agreement for sales and marketing across the Middle East.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/13